Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THINC: Treatments for Hospitalized COVID-19 Patients
NCT04528927Phase 3Withdrawn
- Sponsor
- Abderrahmane Mami Hospital
- Start
- May 2020
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydroxychloroquine, zinc, doxycycline in coronavirus disease 2019 (COVID-19), sponsored by Abderrahmane Mami Hospital. Planned start May 2020; status: withdrawn.
02
Drugs
hydroxychloroquinezincdoxycycline
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04528927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04528927.